Design, synthesis and biological evaluation of novel coumarin-based benzamides as potent histone deacetylase inhibitors and anticancer agents-Reference-Cited by-同舟云学术

Design, synthesis and biological evaluation of novel coumarin-based benzamides as potent histone deacetylase inhibitors and anticancer agents

Published:2017-05 Issue: Volume:132 Page:42-62
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Abdizadeh Tooba,Kalani Mohammad Reza,Abnous Khalil,Tayarani-Najaran Zahra,Khashyarmanesh Bibi Zahra,Abdizadeh Rahman,Ghodsi Razieh,Hadizadeh Farzin^ORCID

Funder

Mashhad University of Medical Sciences

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference51 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J. Clin.,2015

2. Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids;Nepali;Eur. J. Med. Chem.,2014

3. The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men;Yang;Nat. Rev. Mol. Cell. Biol.,2008

4. Histone deacetylase inhibitors;Monneret;Eur. J. Med. Chem.,2005

5. Anticancer activities of histone deacetylase inhibitors;Bolden;Nat. Rev. Drug. Discov.,2006

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of class I HDAC modulators: Inhibitors and degraders;European Journal of Medicinal Chemistry;2024-10

2. Heterocycles–Containing HDAC Inhibitors Active in Cancer: An Overview of the Last Fifteen Years;ChemMedChem;2024-08-29

3. Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship;European Journal of Medicinal Chemistry;2024-08

4. Synthesis and structural optimization of oncolytic peptide LTX-315;Bioorganic & Medicinal Chemistry;2024-06

5. Coumarin as an Elite Scaffold in Anti-Breast Cancer Drug Development: Design Strategies, Mechanistic Insights, and Structure–Activity Relationships;Biomedicines;2024-05-27